131I whole-body scan or 18FDG PET/CT for patients with elevated thyroglobulin and negative ultrasound?

about

Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.

P2860

Q39103120-88140716-3AF5-400F-BD3E-6746DEB599DA

P2860

131I whole-body scan or 18FDG PET/CT for patients with elevated thyroglobulin and negative ultrasound?

Item

http://www.wikidata.org/entity/Q58005415

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2013

@uk

name

131I whole-body scan or 18FDG ...... bulin and negative ultrasound?

@en

131I whole-body scan or 18FDG ...... bulin and negative ultrasound?

@nl

type

Item

label

131I whole-body scan or 18FDG ...... bulin and negative ultrasound?

@en

131I whole-body scan or 18FDG ...... bulin and negative ultrasound?

@nl

prefLabel

131I whole-body scan or 18FDG ...... bulin and negative ultrasound?

@en

131I whole-body scan or 18FDG ...... bulin and negative ultrasound?

@nl

P1476

131I whole-body scan or 18FDG ...... bulin and negative ultrasound?

@en

P2093

Arnoldo Piccardo

http://www.w3.org/2001/XMLSchema#string

Francesco Bertagna

http://www.w3.org/2001/XMLSchema#string

Giorgio Treglia

http://www.w3.org/2001/XMLSchema#string

Luca Giovanella

http://www.w3.org/2001/XMLSchema#string

P2860

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

The role of TSH for 18F-FDG-PET in the diagnosis of recurrence and metastases of differentiated thyroid carcinoma with elevated thyroglobulin and negative scan: a meta-analysis.

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective.

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview

Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Associat

Thyroid cancer--indications and opportunities for positron emission tomography/computed tomography imaging.

The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview.

131I therapy for elevated thyroglobulin levels.

P2888

s40336-013-0024-0

P304

175-183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40336-013-0024-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

131I whole-body scan or 18FDG PET/CT for patients with elevated thyroglobulin and negative ultrasound?

about

P2860

P2860

131I whole-body scan or 18FDG PET/CT for patients with elevated thyroglobulin and negative ultrasound?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577